High-performance PEGylated Mn-Zn ferrite nanocrystals as a passive-targeted agent for magnetically induced cancer theranostics

Biomaterials

Volumn 35, Issue 33, 2014, Pages 9126-9136

  Xie, Jun ^a   Zhang, Yu ^a   Yan, Caiyun ^b   Song, Lina ^a   Wen, Song ^c   Zang, Fengchao ^c   Chen, Gong ^a   Ding, Qi ^a   Yan, Changzhi ^a   Gu, Ning ^a  

^a Southeast University   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

High performance; Mn Zn ferrite nanocrystals; Passive targeting; PEGylation; Theranostics

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BIOCOMPATIBILITY; CELL DEATH; MAGNETIC RESONANCE IMAGING; MAMMALS; MANGANESE; NANOCRYSTALS; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; ZINC;

HIGH-PERFORMANCE; MN-ZN FERRITES; PASSIVE TARGETING; PEGYLATION; THERANOSTICS;

TUMORS;

COPOLYMER; FERRITE; GLYCEROPHOSPHOETHANOLAMINE; MACROGOL; MAGNETITE NANOPARTICLE; MANGANESE; MANGANESE ZINC FERRITE NANOCRYSTAL; NANOCRYSTAL; PHOSPHOLIPID; UNCLASSIFIED DRUG; ZINC; BIOMATERIAL; FERRIC ION; MACROGOL DERIVATIVE; NANOPARTICLE;

ALTERNATING CURRENT; ALTERNATING CURRENT MAGNETIC FIELD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BREAST CARCINOMA; CANCER INHIBITION; CANCER THERANOSTICS; CANCER THERAPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG RETENTION; DRUG TARGETING; EXPERIMENTAL HYPERTHERMIA; FEMALE; MAGNETIC FIELD; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHAGOCYTOSIS; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; MAGNETISM; NEOPLASMS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FERRIC COMPOUNDS; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MICE; MICE, INBRED BALB C; NANOPARTICLES; NEOPLASMS; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS;

EID: 84906783648     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.07.019     Document Type: Article

References (42)

1. Jun Y.W., Lee J.H., Cheon J. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Ed 2008, 47:5122-5135.
2. Yu M.K., Jeong Y.Y., Park J., Park S., Kim J.W., Min J.J., et al. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy invivo. Angew Chem Int Ed 2008, 47:5362-5365.
3. Chen Z.W., Yin J.J., Zhou Y.T., Zhang Y., Song L.N., Song M.J., et al. Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity. ASC Nano 2012, 6:4001-4012.
4. Lee J.H., Jang J.T., Choi J.S., Moon S.H., Noh S.H., Noh S.H., et al. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol 2011, 6:418-422.
5. Liu D.F., Wu W., Ling J.J., Wen S., Gu N., Zhang X.Z. Effective PEGylation of iron oxide nanoparticles for high performance invivo cancer imaging. Adv Funct Mater 2011, 21:1498-1504.
6. Lee N., Choi Y., Lee Y.J., Park M., Moon W.K., Chio S.H. Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r2 relaxivity for highly sensitive invivo MRI of tumors. Nano Lett 2012, 12:3127-3131.
7. Huang H.S., Hainfeld J.F. Intravenous magnetic nanoparticle cancer hyperthermia. Int J Nanomed 2013, 8:2521-2532.
8. Balivada S., Rachakatla R.S., Wang H.W., Samarakoon T.N., Dani R.K., Pyle M., et al. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study. BMC Cancer 2010, 10:119.
9. Hayashi K., Nakamura M., Sakamoto W., Yogo T., Miki H., Ozaki S., et al. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics 2013, 3:366-376.
10. Yoo D., Lee J.H., Shin T.H. Theranostic magnetic nanoparticles Cheon. JAcc Chem Res 2011, 44:863-874.
11. Hilger I., Kaiser W.A. Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine 2012, 7:1443-1459.
12. Mornet S., Vasseur S., Grasset F., Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. JMater Chem 2004, 14:2161-2175.
13. Jang J.T., Nah H., Lee J.H., Moon S.H., Kim M.J., Cheon J. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. Angew Chem Int Ed 2009, 48:1234-1238.
14. Xie J., Yan C.Z., Zhang Y., Gu N. Shape evolution of "multibranched" Mn-Zn ferrite nanostructures with high performance: a transformation of nanocrystals into nanoclusters. Chem Mater 2013, 25:3702-3709.
15. 4 nanocrystals. JAm Chem Soc 2009, 131:12900-12901.
16. 4 nanocrystals. Chem Mater 2009, 21:3458-3468.
17. Kumagai M., Sarma T.K., Cabral H., Kaida S., Sekino M., Herlambang N. Enhanced invivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties. Macromol Rapid Commun 2010, 31:1521-1528.
18. Tong S., Hou S.J., Zheng Z.L., Zhou J., Bao G. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett 2010, 10:4607-4613.
19. Gu L., Fang R.H., Sailor M.J., Park J.H. Invivo clearance and toxicity of monodisperse iron oxide nanocrystals. ACS Nano 2012, 6:4947-4954.
20. Ma Y., Tong S., Bao G., Gao C., Dai Z.F. Indocyanine green loaded SPIO nanoparticles with phospholipid-PEG coating for dual-modal imaging and photothermal therapy. Biomaterials 2013, 34:7706-7714.
21. May J.P., Li S.D. Hyperthermia-induced drug targeting. Expert Opin Drug Deliv 2013, 10:511-527.
22. Bae K.H., Park M., Do M.J., Lee N., Ryu J.H., Kim G.W., et al. Chitosan oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia. ACS Nano 2012, 6:5266-5273.
23. Chatterjee D.K., Diagaradjane P., Krishnan S. Nanoparticle-mediated hyperthermia in cancer therapy. Ther Deliv 2011, 2:1001-1014.
24. Stone R., Willi T., Rosen Y., Mefford O.T., Alexis F. Targeted magnetic hyperthermia. Ther Deliv 2011, 2:815-838.
25. 4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance. JNanomed 2012, 7:2261-2269.
26. Jun Y.W., Huh Y.M., Choi J.S., Lee J.H., Song H.T., Kim S., et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. JAm Chem Soc 2005, 127:5732-5733.
27. Song M.J., Zhang Y., Hu S.L., Song L.N., Dong J.L., Chen Z.P., et al. Influence of morphology and surface exchange reaction on magnetic properties of monodisperse magnetite nanoparticles. Coll Surf A Physicochem Eng Asp 2012, 408:114-121.
28. Harvey A.E., Smart J.A., Amis E.S. Simultaneous spectrophotometric determination of iron(II) and total iron with 1,10-phenanthroline. Anal Chem 1955, 27:26-29.
29. Maeng J.H., Lee D.H., Jung K.H., Bae Y.H., Park I.S., Jeong S., et al. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials 2010, 31:4995-5006.
30. Chen W.H., Xu X.D., Jia H.Z., Lei Q., Luo G.F., Cheng S.X., et al. Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy invivo. Biomaterials 2013, 34:8798-8807.
31. 4 nanomicelles for invivo MR imaging. JNanosci Nanotechnol 2014, 14:1-8.
32. Wang H.S., Fei B.W. Diffusion-weighted MRI for monitoring tumor response to photodynamic therapy. JMagn Reson Imaging 2010, 32:409-417.
33. Turkbey B., Aras O., Karabulut N., Turgut A.T., Akpinar E., Alibek S., et al. Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging. Diagn Interv Radiol 2012, 18:46-59.
34. Li Z.M., Zhao Y.W., Zhao C.J., Zhang X.P., Chen L.J., Wei Y.Q., et al. Hyperthermia increases the therapeutic efficacy of survivinT34A in mouse tumor models. Cancer Biol Ther 2011, 12:523-530.
35. Nishimura Y., Shibamoto Y., Jo S., Akuta K., Hiraoka M., Takahashi M., et al. Relationship between heat-induced vascular damage and thermosensitivity in four mouse tumors. Cancer Res 1988, 48:7226-7230.
36. Roca C., Primo L., Valdembri D., Cividalli A., Declerck P., Carmeliet P., et al. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. Cancer Res 2003, 63:1500-1507.
37. Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7:71-82.
38. Alexis F., Pridgen E., Molnar L.K., Farokhzad O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharmacol 2008, 5:505-515.
39. Longmire M., Choyke P.L., Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 2008, 3:703-717.
40. Barreto J.A., O'Malley W., Kubeil M., Graham B., Stephan H., Spiccia L. Nanomaterials: applications in cancer imaging and therapy. Adv Mater 2011, 23:18-40.
41. Branquinho L.C., Carriao M.S., Costa A.S., Zufelato N., Sousa M.H., Miotto R., et al. Effect of magnetic dipolar interactions on nanoparticle heating efficiency: implications for cancer hyperthermia. Sci Rep 2013, 3:1-10.
42. Stanley S.A., Gagner J.E., Damanpour S., Yoshida M., Dordick J.S., Friedman J.M. Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science 2012, 336:604-607.